The Dow closed at an all-time high on August 3, 2026. Nasdaq jumped 2.1%, S&P 500 up 1.5%. The twist: the very stocks driving these gains are hemorrhaging cash at rates unseen in two decades.

Alphabet just posted negative free cash flow for Q2 2026, the first time since Google's 2004 IPO. Amazon burned through $7.6 billion in trailing-12-month free cash flow. Meta's cash generation collapsed 91% year-over-year. The culprit is relentless AI spending that's reshaping corporate finance.

The AI arms race eating balance sheets

Alphabet alone plans to spend $205 billion on capital expenditure this year. That's roughly Greece's entire GDP. Microsoft, Amazon, Meta, and Oracle are locked in a spending war that's already warping the numbers. A Reuters analysis shows these five hyperscalers will collectively outspend their operating cash flow on capex by 2027, with capital expenditure growth running 1.57 times faster than cash flow growth.

These companies used to reward shareholders with buybacks and fat dividends pulled from enormous free cash reserves. Now they're tapping debt markets and liquidating cash piles just to fund infrastructure. Evercore ISI analysts flagged this shift as a serious valuation red flag tied directly to the trajectory of AI capex.

Why the market doesn't care yet

Tech names are so dominant in major indices that their rallies drag the whole market higher regardless of what's happening in the engine room. When Nasdaq pops 2.1% in a day, a huge chunk comes from a handful of stocks. Goldman Sachs strategist Peter Oppenheimer suggested that tightening free cash flow yields in tech could eventually push money into other corners of the market.

For now, risk appetite remains broad. AI labs continue racing to build despite market turbulence, and digital assets have increasingly moved in sync with tech-heavy indices. When Nasdaq hits new records, crypto and broader risk assets tend to follow.

This material is for informational purposes only and should not be construed as financial advice or investment recommendation.